Abstract
Viral infections may induce an acquired form of immunodeficiency, generally lasting a few weeks. In the more severe form, such as HIV infection, the immunodeficiency is permanent. Programmed death of T cells represents one of the mechanisms by which HIV determines the T cell functional impairment, finally resulting in the destruction of T cells. In this study, we evaluated whether an altered regulation of apoptosis was also implicated in the anergy associated with the common measles or varicella-zoster virus (VZV) infections in infancy. A spontaneous apoptosis of peripheral blood mononuclear cells was observed in children who had suffered from these infections as long as 6 mo after the acute disease. Apoptosis was demonstrated through analysis of cellular DNA content, morphologic evidence of cell nuclei shrinkage, and by analysis of DNA degradation. Stimulation of T cells through anti-CD4 MAb increased the number of apoptotic cells with a maximal effect 72 h after the stimulation. Our results suggest that apoptosis may account for the anergy that follows acute viral infections in infancy.
Similar content being viewed by others
Main
Several viruses causing infectious diseases of infancy may be associated with impairment of various immunologic functions of either B or T cell immunity(1). These acquired forms of immunodeficiency are generally transient in nature, even though in a few cases they may result in permanent anergy(1). As a clinical consequence, viral induced immunodeficiencies lead to a great variety of manifestations that differ in the severity of clinical signs and long-term outcome. The more remarkable example of a severe viral induced immunodeficiency is represented by AIDS, associated with HIV-1 infection, that has caused almost 2 million deaths in the past years(2). Measles and varicella may lead to life-threatening complications that still account for over 1 million deaths per year, due to the wide spread of these viruses in the overall population(3, 4). Children who have recently suffered from these diseases may have immunologic abnormalities, including decreased cell-mediated hypersensitivity and low percentages of circulating CD4+ lymphocytes, which in a few cases may persist for a prolonged time(5–7).
Programmed cell death or apoptosis is an active phenomenon involved in either the differentiation processes within the immune system or homeostasis of tissue turnover(8, 9). In the immune system, apoptosis limits clonal expansion and participates in the intrathymic negative selection of the TCR repertoire(10). Hallmarks of this process are changes in cell morphology and DNA degradation in nucleosomes of multiples of 200 bp by the activation of endogenous nucleases(11, 12). Peripheral blood T cells are resistant to apoptosis, even though it has been reported that CD4 cross-linking primes T cells for apoptosis after subsequent TCR stimulation(13–15). In addition, prolonged stimulation may lead to the activation of the apoptotic cell death program, suggesting that mature T cells can be triggered, under certain circumstances, to undergo apoptosis(16).
A dysregulation of apoptosis is now emerging as a possible cause of human diseases(17, 18). In HIV-infected individuals, enhanced spontaneous or activation-induced apoptosis of T lymphocytes is a well established feature(19, 20). In certain neurodegenerative disorders, such as spinal muscular atrophy(21) and Alzheimer's disease, a failure in the regulatory control of apoptosis is believed to play a pathogenetic role(22, 23).
The Fas/Apo-1 (CD95) surface molecule is involved in the process, and its ligation mediates DNA fragmentation(24–26). In CD4+ and CD8+ populations, obtained from cytomegalovirus and VZV seropositive subjects, and cultured in the presence of cytomegalovirus or VZV antigen, the expression of Fas increased significantly(27).
To ascertain whether a dysregulation of apoptosis may also be associated with the partial anergy that follows infection with anergizing viruses, PBMC from children, who had been affected by measles or VZV infection, were examined for spontaneous or activation-induced apoptosis.
METHODS
Subjects. Fifteen previously healthy children (3 girls and 12 boys; mean age, 72 mo; age range, 10 mo to 12 y), who had received a diagnosis of measles or varicella during the previous 6 mo, were enrolled into the study. Diagnosis was based on the typical clinical features and on the presence of specific antibodies. No clinical or laboratory evidence of HIV infection or clinical signs of an underlying immunodeficiency were present. Fifteen age-matched healthy control subjects were also studied. No signs suggestive of measles or varicella were noted in the clinical history of the control subjects, nor were they immunized against measles.
Immunophenotype analysis and proliferation assays. Immunophenotyping was performed by flow cytometry (FACS-can® Becton Dickinson, San Jose, CA) using the following MAb: CD3 (Leu-4), CD4 (Leu-3a), CD8 (Leu-2a), CD19 (Leu-12), CD56 (Leu-19) (Becton Dickinson, San Jose, CA), CD95 (Fas) (Immunotech, Marseilles, France). HLA class II molecules (HLA-DR; Becton Dickinson) were detected on CD3+ cells by two-color immunofluorescence.
The proliferative response was evaluated in triplicate cultures of 2× 105 PBMC, obtained by Ficoll-Hypaque (Biochrom, Berlin, Germany) density gradient centrifugation by standard procedures. Cultures were pulsed with 1 μCi/well of [3H]thymidine (Amersham International, Buckinghamshire, England) for the last 16 h and then harvested. The following stimuli were used: 8 μg/mL PHA (Difco Laboratories, Detroit, MI), 1:200 final dilution Pokeweed mitogen (Life Technologies Ltd, Paisley, Scotland), 8.5 μg/mL concanavalin A (Difco Laboratories), 20 ng/mL PMA + 0.5 mM ionomycin (Sigma Chemical Co., St. Louis, MO). CD3 cross-linking was performed by precoating culture plates with 10 and 1 ng/mL anti-CD3 purified MAb (4B6, gift of Dr. C. Morimoto, Dana Farber Cancer Institute, Boston, MA). In experiments performed with T cell blasts, PBMC were stimulated for 48 h with 8μg/mL PHA.
Cell cycle analysis and DNA fragmentation assays. The percentage of apoptotic PBMC was quantitated by PI (Sigma Chemical Co.) staining and flow cytometry on a FACScan cytometer (Becton Dickinson) as previously described(28). In brief, PBMC (1 × 106) from patients and control subjects were cultured for 72 h in medium alone or in the presence of the appropriate stimulant. CD3 and CD4 cross-linking was performed by precoating tissue culture plates with anti-CD3(4B6; 10 ng/mL) and/or CD4 MAbs (ascites, 19THY5D7, dilution 1:200). After culturing, PBMC were washed twice in phosphate buffer solution and then incubated with PI solution containing 0.1% (vol/vol) Triton X-100 (Sigma Chemical Co.), 3.4 mM trisodium citrate, 50 μg/mL PI. After gentle mixing, cells were put on ice in the dark for 1 h and analyzed by the Cell FIT-DNA software (Becton Dickinson).
DNA fragmentation was determined on PBMC, resting or cultured as above described, by analyzing the ladder appearance characteristic of apoptosis. Low molecular weight DNA was obtained from 4 × 106 cells. At the indicated time, PBMC were washed twice in phosphate buffer solution and the cell pellet was lysed in 0.5 mL hypotonic buffer (5 mM Tris-HCl, 20 mM EDTA, 0.5% Triton X-100, pH 8), and centrifuged at 27 000 × g for 20 min. Fragmented DNA in the supernatant was precipitated overnight at -20°C in 650 μL of isopropanol and 100 μL of 5 M sodium chloride. After centrifugation at 27 000 × g for 20 min, the precipitates were air-dried and resuspended in 10 mM Tris, 1 mM EDTA, pH 7.4. Separation of ethidium bromide-stained DNA fragments was performed by 1% agarose gel electrophoresis. The loading buffer contained 15 mM EDTA, 2% SDS, 50% glycerol, and 0.5% bromphenol blue.
Cell morphology and viability. Cell morphology was evaluated by light microscopy of cells cytocentrifuged and stained by May-Grunwald Giemsa. Loss of cell volume, chromatin condensation along the membrane, and nuclear fragmentation were considered indicative of apoptosis.
Statistical analysis. The statistical significance of differences was evaluated by t test, or by Wilcoxon rank sum test for unpaired data, when indicated. Correlation analysis was performed by regression line and F test.
RESULTS
Immunophenotyping and proliferation assays. Immunophenotype analysis revealed that 7 out of 15 children, who had suffered measles or VZV infection, had lower numbers of circulating CD4+ lymphocytes than age-matched control subjects, ranging between 0.43 and 1.02 × 103 cells/mL (Table 1). Eight patients had a lower CD4/CD8 ratio than the control group, values ranging between 0.37 and 0.85. No difference between measles or varicella patients groups was appreciable. In seven patients the expression of the activation marker HLA class II molecules on CD3+ cells was studied. No difference between patients and control subjects was found (3.1 ± 0.8% versus 4.5 ± 1.5%, respectively). We next evaluated the proliferative response of PBMC after stimulation with suboptimal or optimal concentrations of immobilized anti-CD3 MAb, and PMA and ionomycin by assessing [3H]thymidine uptake in short-term cultures. PBMC from four patients had a lower proliferative response to a suboptimal concentration of anti-CD3. Two of these four patients also had a low number of CD4+ lymphocytes, as reported in Table 1. Table 2 illustrates the results in these four patients. Optimal stimulation through CD3 cross-linking or PMA and ionomycin induced a normal or close to normal response. No appreciable differences between patients and controls were noted when potent mitogens, such as PHA or concanavalin A, were used (data not shown).
Cell death in peripheral blood mononuclear cells from children recently infected with measles or VZV. Cell death was investigated in children who had suffered from measles or varicella in the last 6 mo.Figure 1 shows a representative experiment performed to evaluate DNA fragmentation of PBMC. Agarose gel of DNA obtained from patient's PBMC resulted in a clear ladder pattern, indicative of DNA fragmentation in oligonucleosomes containing multiples of 200 bp. Maximal DNA fragmentation was noted after a 72-h incubation with immobilized anti-CD4 MAb (lane 2). In patient's PBMC, DNA fragmentation was also observed after CD3 and CD4 co-stimulation (lane 3) or after an incubation with medium alone (lane 1), but at a lesser extent than that observed after stimulation with anti-CD4 MAb. The ladder appearance was not seen in DNA obtained from freshly isolated PBMC(data not shown) or in DNA from control cells.
Cellular DNA content was also measured through cell cycle analysis by PI staining of PBMC. Figure 2 indicates that patients' PBMC underwent apoptosis after a 72-h incubation in medium alone. The percentage of apoptotic cells were higher in measles and VZV patients than in control subjects. Mean values ± SEM were 11.29 ± 3.93% in measles patients (p < 0.01), 8.98 ± 2.00% in varicella patients(p < 0.01), and 2.33 ± 0.41% in control subjects. Again, no apoptotic cells were found in freshly isolated PBMC. No correlation was found between the percentage of apoptotic cells and the time that had elapsed from the acute disease.
We next investigated whether cell stimulation through MAb against CD4, or CD3 and CD4 molecules in co-stimulation experiments, increased cell apoptosis. A representative experiment (Fig. 3) shows that the maximal apoptotic effect was observed after a 72-h CD4 stimulation. CD3 and CD4 costimulation also increased cell apoptosis, but to a lesser extent than CD4 stimulation alone. In controls, only a slight increase of apoptotic cells after stimulation with anti-CD4 or anti-CD3 and CD4 MAbs was observed, mean values ± SEM being 3.81 ± 0.97% and 3.42 ± 0.57%, respectively. Conversely, in the overall group of patients the percentages of apoptotic cells after stimulation with anti-CD4 or anti-CD3 and CD4 MAbs were 12.97 ± 2.97% (p < 0.01) and 9.72 ± 2.33%(p < 0.02), respectively (Fig. 4). In individual patients these stimulations resulted in increase of the percentage of apoptotic cells compared with that obtained by incubation with medium alone. When the proliferative response to CD3 cross-linking was correlated to the percentage of apoptotic cells, a trend to a negative correlation was found, even though it was not statistically significant due to the limited number of patients in each group (r2 = 0.29; p = 0.14). However, three out of the four patients with a low proliferative response to CD3 cross-linking, identified in the Table 2 as patients 1, 3, 4, and 13, also had high percentages of apoptotic cells, values being 15.4, 13.5, and 11.3%, respectively. Again, no difference between measles and varicella patients was noted. Three patients were tested three times in a 6-mo follow-up for spontaneous or activation induced apoptosis. Results in each patient were homogeneous, indicating that the phenomenon is persistent over time (data not shown).
The morphologic analysis of cells revealed the presence of a considerable number of cells showing loss of cell volume, chromatin condensation, and nuclei fragmentation, indicative of cell apoptosis (Fig. 5). Freshly isolated PBMC were not apoptotic, and a 72-h stimulation with anti-CD3 and -CD4 MAbs increased the number of apoptotic cells.
Fas expression on CD3+ and CD4+ lymphocytes. Surface Fas molecules mediate cell apoptosis, and their expression is up-regulated during cell activation. To define whether the increased spontaneous and activation-induced apoptosis in the patients' group paralleled an abnormal expression of Fas, CD3+, and CD4+ lymphocytes were assayed for Fas expression. Figure 6 shows that no difference between patients and controls was found in the Fas expression of CD3+ and CD4+ cells, when they were either unstimulated or stimulated for 72 h through anti-CD3 and -CD4 MAbs. Similarly, no difference between patients and control subjects was observed in the intracellular expression of the protective bcl-2 molecule (data not shown). Moreover, incubation of PBMC with a saturating concentration of anti-CD95 MAb did not substantially modify the percentages of apoptotic cells, either when they were unstimulated or after CD3 and CD4 cross-linking (data not shown).
DISCUSSION
Our results indicate that PBMC from children, affected in the previous 6 mo by the common measles or VZV infections, are more prone than control cells to die rapidly by an apoptotic pathway. This phenomenon was observed as long as 6 mo after the acute disease, and it was associated in 40% of cases with a persistent low level of circulating CD4+ cells. Although virusinduced immune suppression is a well recognized condition associated with several viral infections, the pathogenetic mechanisms are unknown(1).
Apoptosis is a physiologic process, that plays a key role in the maintenance of homeostasis in the immune response(29, 30). It is involved in tolerance, in autoreactive cell deletion, and in the deletion of activated cells to limit clonal expansion(12, 31). A dysregulation of the process is now emerging as a possible pathogenetic mechanism for various autoimmune, neurologic, and infectious diseases(17, 18, 32). AIDS is the more remarkable example of a viral induced immunodeficiency caused by accelerated apoptosis of peripheral blood lymphocytes(15). This has been ascribed to CD4 cross-linking mediated by the virus envelope protein gp120, inappropriate function of accessory cells, or superantigen activity induced by the virus(15, 33–35). Recent evidence indicates that infection of human thymus with measles virus induces significant thymocyte death, thus supporting the hypothesis that accelerated apoptosis may be involved in the pathogenesis of viral induced immune suppression(36).
As for the measles and VZV life cycle, both viruses can be isolated from mononuclear cells of infected patients only for a short period of time(37, 38). After initial viremia, measles virus undergoes extensive multiplication in the reticuloendothelial system, followed by virus clearance within a few days(4). A persistent measles viral infection, lasting several years, has been documented in the brain of patients with subacute sclerosing panencephalitis, a very rare neurodegenerative disease that affects 0.6-2.2 per 100 000 naturally infected patients(39, 40). VZV belongs to the family of herpesviruses, and in contrast to measles, more frequently remains in a latent form in infected individuals. Transcripts of the viral genome may be identified in ganglia and neuronal cells years after the first contact with the virus(41). The mechanisms responsible for maintenance of latency are not known. Because measles and VZVs can be isolated from the peripheral blood only for a short period of time, a possible explanation for the observation of accelerated apoptosis is that these viruses may be sequestrated in lymphoid or other reservoir organs for a longer time. Eventually, they may indirectly trigger bystander cells to undergo apoptosis in a similar fashion to that which occurs during HIV infection. Indeed, a direct cytopathic effect of HIV is not per se responsible for triggering cell apoptosis(34).
The clinical relevance of our findings remains to be established. It may explain the defect of cell-mediated immunity observed in these patients, and may predispose to secondary infections. Several mechanisms may underlie a failure to induce a productive T cell immune response. Virtually, structural or functional deficiencies of all the molecules involved in the different phases of cell activation may result in an immune defect, as demonstrated by congenital immune defects(42). Moreover, experimental evidence indicates that the absence of the costimulatory signal, provided by members of the B7 family, results in a functional clonal inactivation(43). This condition, called anergy, is a complex phenomenon requiring a differential association of the TCR with specific intracytoplasmic protein kinases, distinct from those involved in the productive immunity(44). Whether a similar mechanism is also implicated in the defect of cell-mediated immunity after infections with measles or VZVs is not known at present. Even though no T cells bearing HLA class II molecules were found in our patients, an additional explanation of the accelerated apoptosis observed in our patients is also that a few cells are in an activation stage, which results in cell death after a further in vitro stimulation through CD3 and CD4 receptors.
Molecular mechanisms that regulate cell apoptosis are not clearly defined at present, Fas/Fas ligand and bcl-2 molecules participate in the process by exerting opposite effects(45, 46). Previous studies indicate that acute viral infections, such as infectious mononucleosis and varicella, may alter the expression of the protective bcl-2 molecule(47, 48), which may be related to the reemergence of the cell death program. TCR-induced apoptosis is mediated by Fas/Fas ligand interaction, and the surface expression of these molecules is up-regulated after stimulation. Expression of Fas on peripheral blood mononuclear cells cultured in vitro with cytomegalovirus and VZV increased significantly, and the surface expression correlated with DNA fragmentation(27). Taken together these observations argue in favor of a major role of these two molecules in regulating the cell death process after an acute viral infection. In our study we found equivalent expression of the Fas protein in either unstimulated CD3+ and CD4+ cells or cells stimulated through CD3 and/or CD4 cross-linking in controls and patients. Similarly, we found comparable expression of bcl-2 in patients' and control subjects' PBMC. Even though in preliminary experiments we could find an increased Fas-induced cytotoxicity in patients, we cannot exclude an involvement of Fas/Fas ligand molecules in the alteration herein described. However, apoptosis is a complex phenomenon under control of a wide number of genes(23, 49, 50). Cytokines and cytokine receptors participate in the regulatory network of apoptosis. In mice, IL-2 and IL-2 receptor α-chain knockouts result in a mulitsystem autoimmune disease, related to defective elimination of previously activated T cells(51). IL-2 and IL-12 both inhibit apoptosis after CD4 cross-linking with the viral protein gp120(52). Therefore, it remains to be established whether the functional abnormalities herein described are related to a more complex immune disorder due to alterations of the cytokine network.
In conclusion, our data indicate that an accelerated cell death process occurs after measles or VZV infections. Whether this phenomenon is a properly regulated physiologic event, leading to the elimination of lymphocytes activated by the viruses, is not clear. An alternative hypothesis is that the accelerated apoptosis may contribute to the immune deficiency that follows some acute viral diseases in infancy.
Abbreviations
- TCR:
-
T cell receptor
- VZV:
-
varicella-zoster virus
- PBMC:
-
peripheral blood mononuclear cells
- PHA:
-
phytohemagglutinin
- PMA:
-
phorbol myristate acetate
- PI:
-
propidium iodide
References
Mims CA 1986 Interactions of viruses with the immune system. Clin Exp Immunol 66: 1–16
Merson MH 1993 Slowing the spread of HIV: agenda for the 1990s. Science 260: 1266–1268
Brunell PA 1992 Varicella-zoster infections. In: Feigin RD, Cherry JD (eds) Textbook of Pediatric Infectious Diseases. WB Saunders, Philadelphia, pp 1587–1591
Cherry JD 1992 Measles. In: Feigin RD, Cherry JD (eds) Textbook of Pediatric Infectious Diseases. WB Saunders, Philadelphia, pp 1591–1609
Arneborn P, Biberfeld G 1983 T-lymphocyte subpopulations in relation to immunosuppression in measles and varicella. Infect Immun 39: 29–37
Joffe MI, Sukha NR, Rabson AR 1983 Lymphocyte subsets in measles. J Clin Invest 72: 971–980
Alpert G, Leibovitz L, Danon YL 1984 Analysis of T-lymphocyte subsets in measles. J Infect Dis 149: 1018
MacDonald HR, Lees RK 1990 Programmed death of autoreactive thymocytes. Nature 343: 642–644
Raff MC 1992 Social controls on cell survival and cell death. Nature 356: 397–400
Blackman M, Kappler J, Marrack P 1990 The role of the T cell receptor in positive and negative selection of developing T cells. Science 248: 1335–1341
Wyllie AH 1980 Glucocorticoid-induced thymocyte apoptosis is associated with endogeneous endonuclease activation. Nature 284: 555–556
Cohen JJ, Duke RC, Fadok VA, Sellins KS 1992 Apoptosis and programmed cell death in immunity. Annu Rev Immunol 10: 267–293
Banda NK, Bernier J, Kurahara DK, Kurrle R, Haigwood N, Sekaly RP, Finkel TH 1992 Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 176: 1099–1106
Kabelitz D, Pohl T, Pechhold K 1993 Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today 14: 338–339
Oyaizu N, McCloskey TW, Coronesi M, Chirmule N, Kalyanaraman VS, Pahwa S 1993 Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 82: 3392–3400
Wesselborg S, Janssen O, Kabelitz D 1993 Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J Immunol 150: 4338–4345
Vaux DL 1993 Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci USA 90: 786–789
Thompson CB 1995 Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456–1462
Meyaard L, Otto SA, Keet IPM, Roos MTL, Miedema F 1994 Programmed death of T cells in human immunodeficiency virus infection. J Clin Invest 93: 982–988
Oyaizu N, Pahwa S 1995 Role of apoptosis in HIV disease pathogenesis. J Clin Immunol 15: 217–231
Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton-Horvat G, Farahani R, McLean M, Ikeda JE, MacKenzie A, Korneluk RG 1996 Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379: 349–353
Kosik KS 1992 Alzheimer's disease: a cell biological perspective. Science 256: 780–783
Vito P, Lacanà E, D'Adamio L 1996 Interfering with apoptosis: Ca2+-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 271: 521–525
Owen-Schaub LB, Yonehara S, Crump WL, Grimm EA 1992 DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by fas antigen engagement. Cell Immunol 140: 197–205
Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S 1993 Lethal effect of the anti-Fas antibody in mice. Nature 364: 806–809
Tucek-Szabo CL, Andjelic S, Lacy E, Elkon KB, Nikolic-Zugic J 1996 Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis. J Immunol 156: 192–200
Ito M, Watanabe M, Ihara T, Kamiya H, Sakurai M 1995 Fas antigen and bcl-2 expression on lymphocytes cultured with cytomegalovirus and varicella-zoster virus antigen. Cell Immunol 160: 173–177
Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C 1991 A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139: 271–279
Howie SEM, Harrison DJ, Wyllie AH 1994 Lymphocyte apoptosis-mechanisms and implications in disease. Immunol Rev 142: 141–156
Abbas AK 1996 Die and let live: eliminating dangerous lymphocytes. Cell 84: 655–657
Mountz JD, Zhou T, Wu J, Wang W, Su X, Cheng J 1995 Regulation of apoptosis in immune cells. J Clin Immunol 15: 1–16
Russell JH, Rush B, Weaver C, Wang R 1993 Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci USA 90: 4409–4413
Weinhold KJ, Lyerly HK, Stanley SD, Austin AA, Matthews TJ, Bolognesi DP 1989 HIV-1 gp120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. J Immunol 147: 3091–3097
Ameisen JC 1994 Programmed cell death (apoptosis) and cell survival regulation: relevance to AIDS and cancer. AIDS 8: 1197–1213
Wu MX, Daley JF, Rasmussen RA, Schlossman SF 1995 Monocytes are required to prime peripheral blood T cells to undergo apoptosis. Proc Natl Acad Sci USA 92: 1525–1529
Auwaerter PG, Kaneshima H, McCune JM, Wiegand G, Griffin DE 1996 Measles virus infection of thymic epithelium in the SCID-hu mouse leads to thymocytes apoptosis. J Virol 70: 3734–3740
Asano Y, Itakura N, Hiroishi Y, Hirose S, Nagai T, Ozaki T, Yazaki T, Yamanishi K, Takahashi M 1985 Viremia is present in incubation period in nonimmunocompromised children with varicella. J Pediatr 106: 69–71
Matumoto M 1966 Multiplication of measles virus in cell cultures. Bacteriol Rev 30: 152–176
Payne FE, Baublis JV, Itabashi HH 1969 Isolation of measles virus from cell cultures of brain from a patient with subacute sclerosing panencephalitis. N Engl J Med 281: 585–589
Center for Disease Control 1982 Measles prevention. MMWR 31: 217–231
Croen KD, Ostrove JM, Dragovich LJ, Straus SE 1988 Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses. Proc Natl Acad Sci USA 85: 9773–9777
Arnaiz-Villena A, Timon M, Gallego CR, Blas MP, Correl A, Villa JMM, Regueiro JR 1992 Human T-cell activation deficiencies. Immunol Today 13: 259–265
Mueller DL, Jenkins MK, Schwartz RH 1989 Clonal expansion versus functional clonal inactivation: a co-stimulatory signalling pathway determines the outcome of the T cell antigen receptor occupancy. Annu Rev Immunol 7: 445–480
Boussiotis VA, Barber DL, Lee BJ, Gribben JG, Freeman GJ, Nadler ML 1996 Differential association of protein tyrosine kinase with the T cell receptor is linked to the induction of anergy and its prevention by B7 family-mediated costimulation. J Exp Med 184: 365–376
Ju ST, Panka DJ, Cul H, Ettinger R, El-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A 1995 Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373: 444–448
Akbar AN, Salmon M, Savill J, Janossy G 1993 A possible role for bcl-2 in regulating T-cell memory-a balancing act between cell death and survival. Immunol Today 14: 526–532
Tamaru Y, Miyawaki T, Iwai T, Tsuji T, Nibu R, Yachie A, Koizumi S, Taniguchi N 1993 Absence of bcl-2 expression by activated CD45RO+ T lymphocytes in acute infectious mononucleosis supporting their susceptibility to programmed cell death. Blood 82: 521–527
Akbar AN, Borthwick N, Salmon M, Gombert W, Bofill M, Shamsadeen N, Pilling D, Pett S, Grundy JE, Janossy G 1993 The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J Exp Med 178: 427–438
Vaux DL, Strasser A 1996 The molecular biology of apoptosis. Proc Natl Acad Sci USA 93: 2239–2244
Steller H 1995 Mechanisms and genes of cellular suicide. Science 267: 1445–1449
Willerford DM, Chen I, Ferry IA, Davidson L, Ma A, Alt FW 1995 Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3: 521–530
Radrizzani M, Accornero P, Amidei A, Aiello A, Delia D, Kurrle R, Colombo MP 1995 IL-12 Inhibits apoptosis induced in a human Th1 clone by gp120/CD4 cross-linking and CD3/TCR activation or by IL-2 deprivation. Cell Immunol 161: 14–21
Author information
Authors and Affiliations
Additional information
This article is dedicated to Prof. Armido Rubino for his 60th birthday.
Rights and permissions
About this article
Cite this article
Pignata, C., Fiore, M., De Filippo, S. et al. Apoptosis as a Mechanism of Peripheral Blood Mononuclear Cell Death after Measles and Varicella-Zoster Virus Infections in Children. Pediatr Res 43, 77–83 (1998). https://doi.org/10.1203/00006450-199801000-00012
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-199801000-00012
This article is cited by
-
Altered regulatory mechanisms governing cell survival in children affected with clustering of autoimmune disorders
Italian Journal of Pediatrics (2012)